Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Xact Bear XACTBEAR Apr 15, 2021 25.02 -1.09   
 Xact Bear 2 XACTBEAR2 Apr 15, 2021 14.96 -1.49   
 Xact Bull XACTBULL Apr 15, 2021 641.90 +1.10   
 Xact Bull 2 XACTBULL2 Apr 15, 2021 1 390.20 +1.46   
 XACT Högutdelande XACTHDIV Apr 15, 2021 132.50 +0.76   
 Xact OMXS30 XACTOMXS30 Apr 15, 2021 288.65 +0.73   
 XANO Industri B XANOB Apr 15, 2021 162.50 +1.88   
 Xavitech B XAVIB Apr 15, 2021 1.57 +15.02   
 Xbrane Biopharma XBRANE Apr 15, 2021 95.00 -4.04   
 Xintela XINT Apr 15, 2021 3.17 -2.16   
 XMReality XMR Apr 15, 2021 6.71 -0.15   
 Xspray Pharma XSPRAY Apr 15, 2021 81.00 +1.31   
 Xvivo Perfusion XVIVO Apr 15, 2021 312.00 +9.28   
 XXL XXLO Apr 15, 2021 19.00 0.00   
 Yara International YARO Apr 15, 2021 448.80 0.00   
 Ytrade Group YAYTRD Apr 15, 2021 3.97 0.00   
 Zalaris ZALO Apr 15, 2021 54.20 0.00   
 Zaplox ZAPLOX Apr 15, 2021 0.51 +51.11   
 Zenergy B ZENZIPB Apr 15, 2021 0.34 +22.78   
 Zenicor ZENI Apr 15, 2021 12.00 0.00   
 ZetaDisplay ZETA Apr 15, 2021 20.00 -4.31   
 Ziccum AB ZICC Apr 15, 2021 19.20 +0.10   
 ZignSec ZIGN Apr 15, 2021 17.26 +0.47   
 Zinzino B ZZB Apr 15, 2021 85.70 +6.06   
 Zoomability ZOOM Apr 15, 2021 16.42 +0.12   
 Zordix B ZORDIXB Apr 15, 2021 38.75 +0.78   
 Zutec ZUTEC Apr 15, 2021 5.39 +3.85   
 Zwipe ZWIPE Apr 15, 2021 30.98 +3.40   
 ÅF Pöyry B AFB Apr 15, 2021 283.80 -0.49   
 Öresund ORES Apr 15, 2021 151.40 +0.93   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK